Could a simple vitamin A and zinc supplement help protect young children from malaria? A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
Jean-Bosco Ouedraogo of the Institut de Recherche en Sciences de la Santé (IRSS) in Bobo Dioulasso, Burkina Faso, and colleagues explain that vitamin A and zinc play a critical role in the normal function of the immune system, and may even play a synergistic role for reducing the risk of infection including malaria caused by Plasmodium falciparum.
There are approximately 300 to 500 million new cases of malaria each year across the globe, primarily due to P. falciparum.,The vast majority of cases occur in sub-Saharan Africa and lead to the death o f about one million children each year. Emerging drug resistance and ineffective insecticides used in malaria control have hampered efforts to reduce these figures. Moreover, people living in malaria-endemic areas often suffer from malnutrition and deficiencies of micronutrients such as vitamin A and zinc, which have serious health consequences.
In order to understand how reducing micronutrient deficiencies might influence malaria incidence, the researchers undertook a trial with a single dose of 200,000 IU of vitamin A and daily 10 mg of zinc supplementation in children aged 6 to 72 months in the village of Sourkoudougou in Burkina Faso. Half were given placebo. They evaluated the children daily for signs of fever and analyzed blood samples for the presence of the malaria parasite in those children with fever.
The researchers found a significant effect of vitamin A and zinc supplementation on malaria incidence. "At the end of the study we observed a significant decrease in the prevalence malaria in the supplemented group (34%) compared to the placebo group (3.5%)," they explained. Supplementation also increased the time to onset of malarial symptoms and reduced the frequency of episodes. "Supplementation thus may play a key role in malaria control strategies for children in Africa," they added.
Source: BioMed Central
Related stories:
House ready to OK $48B in global AIDS fight
(AP) -- Expanding on a program that has saved and prolonged the lives of millions in Africa alone, the House prepared Thursday to pass and send to President Bush legislation that triples money to fight AIDS, malaria and tuberculosis around the world.
Malaria Millennium Development Goal 'unlikely to be met'
The Millennium Development Goal (MDG) to halt and begin to reverse the incidence of malaria globally is unlikely to be met, according to Wellcome Trust Principal Research Fellow Professor Bob Snow. The statement comes in a report published today in the open access journal
PLoS Medicine.
Senate agrees to triple anti-AIDS funding
(AP) -- The Senate voted Wednesday to triple spending for a much-acclaimed program that has treated and protected millions in Africa and elsewhere from the scourges of AIDS, malaria and tuberculosis.
Identifying and disrupting key elements of malaria's 'sticky sack' adhesion strategy
Malaria is one of the most devastating diseases afflicting humanity. It infects and debilitates about 600 million people and kills up to three million people every year, mainly in the wet tropical regions of the world. Children and pregnant women are at particularly high risk.
Discovery of key malaria proteins could mean sticky end for parasite
Scientists funded by the Wellcome Trust have identified a key mechanism that enables malaria-infected red blood cells to stick to the walls of blood vessels and avoid being destroyed by the body's immune system. The research, published today in the journal
Cell, highlights an important potential new target for anti-malarial drugs.
Plasmodium vivax -- challenging the dogma of being 'benign'
Plasmodium. vivax can cause severe malaria associated with substantial morbidity and mortality, show two studies published in
PLoS Medicine this week. These findings challenge the current dogma that P. falciparum can be severe and life-threatening whereas P. vivax tends to be mild, according to the related commentary by Stephen Rogerson (University of Melbourne, Australia), an expert not connected with these studies.
New MRI to debut in African nation of Malawi; will save lives, advance malaria research
Michigan State University physician Terrie Taylor studies cerebral malaria in Malawi where the vast majority of malaria patients are children. And, in order to get a closer look at the damage malaria does to a child, Taylor and colleagues study the child's brain, something that, up until now, could only be done in an autopsy.
Elusive protein protects malaria parasite from heme
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have identified Heme Detoxification Protein, a unique protein encoded in the malaria genome that represents a potential target for developing new malaria drugs.